INTRODUCTION
Peritoneum is one of the most frequent sites of metastasis in pancreatic cancer [1] . However, it is difficult to detect microscopic disease spread in the peritoneum during the operation unless it forms visible lesions in the peritoneum. Peritoneal cytology has been used as clinical parameters for prognostication of gastric [2] or gynecologic malignancies [3] . However, the role and prognostic relevance of peritoneal cytology for pancreatic cancer have not been well defined. Some have reported positive peritoneal cytology as a poor prognostic factor of pancreatic cancer [4, 5] , but others have regarded positive cytology without any other evidence of distant metastasis not as an independent prognostic factor for overall survival of pancreatic cancer [6] [7] [8] . [4] [5] [6] [7] [8] [9] [10] . However, conventional cytologic examination has limited sensitivity for detecting peritoneal micrometastasis, and it can have biased results according to pathologists. A recent study reported increased sensitivity of cytologic examination using reverse transcription-polymerase chain reaction for the peritoneal fluid of pancreatic cancer patients [11] , or using fluorescent in situ hybridization (FISH) for brush cytologic examination for patients with malignant biliary obstruction [12] and pancreatic cancer [13] .
In this study, the authors investigated the prognostic relevance of cytologic examination of peritoneal washing and postoperative peritoneal drainage fluid using the FISH technique in potentially resectable pancreatic cancer patients. probe; Vysis Inc., Downers Grove, IL, USA) was hybridized with the prepared slide. After 3 minutes of denaturation at 75°C, the slide was incubated for 24 hours at 39°C. Values are presented as mean ± standard deviation, number (%), or median (range). FISH, fluorescent in situ hybridization. 
METHODS

RESULTS
The demographic findings of the study subjects are listed in Table 1 . The mean age of the study subjects was 60.1 years and the male to female ratio was 2.5 to 1. Surgery with curative intent was performed in 25 patients (89.3%).
None of the patients had malignant cells detected with
Papanicolaou's method. The detection rates for p53 deletion in the peritoneal washing fluid and peritoneal drainage fluid were 32.1% (n = 9, Fig. 1 ) and 17.9% (n = 5), respectively. p53 deletion was not detected in any of the peritoneal washing or peritoneal drainage fluids in 13 patients (46.4%), and p53 deletion was detected in both the peritoneal washing and peritoneal drainage fluid in 1 patient (3.6%). Twenty-three patients (82.1%) received adjuvant treatment. Fourteen patients (77.8%) had concurrent chemoradiation therapy followed by gemcitabine based maintenance chemotherapy. One patient (5.6%) had radiation therapy only, and 5 patients (27.8%) had gemcitabine based chemotherapy only. All of the patients were followed up for survival analysis for at least 5 years.
Twenty-three patients (82.1%) died during the follow-up period, and 25 patients (89.3%) experienced recurrence.
The pathologic characteristics of the patients are presented in Table 2 . Lymph node metastasis was identified in 20 patients (71.4%) and 7 patients (25.0%) had microscopic positive resection margin.
Tumor characteristics according to p53 deletion
Nine patients (32.1%) had p53 deletion detected in the peritoneal washing fluid. Patients with p53 deletion detected in the peritoneal washing fluid had comparable T stage (T3, 9/9 vs. 18/19, P = 1.000), lymph node metastasis (6/9 vs. 14/19, P = 1.000), perineural invasion (9/9 vs. 15/19, thesurgery.or.kr Values are presented as number (%). 
Survival outcome according to p53 deletion
Overall median survival of the study subjects was 17. 
Prognostic factors for disease free survival of resectable pancreas cancer
Disease free survival of resectable pancreas cancer was associated with surgery with curative intent (P = 0.015) or lymphovascular invasion (P = 0.058). Peritoneal metastasis free survival was associated with surgery with curative intent (P ＜ 0.001), p53 deletion detected in peritoneal drain- age fluid (P = 0.030), and positive resection margin (P = 0.093) ( Table 4) . From the multivariate analysis, palliative resection and p53 deletion detected in the peritoneal drainage fluid were independent factors for peritoneal metastasis free survival (Table 5) .
DISCUSSION
Most pancreatic cancers have cytogenetic alterations.
Human pancreatic cancers usually have an increased copy number of c-myc, a decreased copy number of p16, deletion of p53, loss of chromosome 18q and gain of chromosome 20q [13] . Our previous study showed that all of the pancreatic cancer tissues had p53 deletions detected by the FISH technique [13] . As a consequence, the authors selected p53 deletion as a cancer cell detection marker in peritoneal washing and peritoneal drainage fluid.
The clinical impact of peritoneal cytology for pancreatic cancer is under debate. Poor survival outcomes in patients with positive peritoneal cytology have been suggested [7, 11] but some have reported that positive peritoneal cytology alone does not contraindicate radical surgery in patients with resectable pancreatic cancer [6, 8, 14, 15] . Moreover, positive cytology is not a contraindication of curative surgery for colon cancer [16] or gynecological cancers [17] .
In this study, there were no patients with positive cytology 
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